Cite
HARVARD Citation
Reinisch, W. et al. (2015). A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease. Scandinavian journal of gastroenterology. pp. 1226-1233. [Online].